Cargando…
Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab
Breast cancer related lymphedema (BCRL) is frequent but strategies for an individualized risk assessment are lacking. We aimed to define whether tumor-specific pathological features, coupled with clinical and therapeutic data, could help identify patients at risk. Data from 368 patients with node-po...
Autores principales: | Invernizzi, Marco, Michelotti, Anna, Noale, Marianna, Lopez, Gianluca, Runza, Letterio, Giroda, Massimo, Despini, Luca, Blundo, Concetta, Maggi, Stefania, Gambini, Donatella, Fusco, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406664/ https://www.ncbi.nlm.nih.gov/pubmed/30682851 http://dx.doi.org/10.3390/jcm8020138 |
Ejemplares similares
-
Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up
por: Invernizzi, Marco, et al.
Publicado: (2018) -
Updates on Lymphovascular Invasion in Breast Cancer
por: Kuhn, Elisabetta, et al.
Publicado: (2023) -
Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema
por: Invernizzi, Marco, et al.
Publicado: (2020) -
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
por: Sajjadi, Elham, et al.
Publicado: (2021) -
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
por: Lopez, Gianluca, et al.
Publicado: (2020)